The RECOVER ( Randomized Evaluation of the 24-hour Coverage : Efficacy of Rotigotine ; Clintrials.gov : NCT00474058 ) study demonstrated significant improvements in early-morning motor function ( UPDRS III ) and sleep disturbances ( PDSS-2 ) with rotigotine transdermal system .